Skip to main content

Pacira BioSciences, Inc.

PCRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001396814

In the last 90 days, Pacira BioSciences, Inc. insiders filed 0 open-market purchases and 1 sale; 254 institutions reported holding it in 13F filings for Q2 2026, worth $1.11B in total; no superinvestor holds it.

Q1 2026 vs. Q4 2025

How the institutions holding Pacira BioSciences, Inc. changed between Q4 2025 and Q1 2026.

All holders in Q1 2026All holders in Q4 2025

13F holders of PCRX: Q4 2025 compared with Q1 2026
MeasureQ4 2025Of which not filed for Q1 2026Q1 2026Change
Holders2615242−14
Shares47.0M4.83M43.6M+1.48M (+3.5%)
Value$1.22B$124.9M$986.2M−$104.2M (−9.6%)

5 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (29)

Institutions that held Pacira BioSciences, Inc. at the end of Q1 2026 but not at the end of Q4 2025.

Sold out (43)

Institutions that held Pacira BioSciences, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of PCRX in Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Assenagon Asset Management S.A.435,143$11.3M
Healthcare of Ontario Pension Plan Trust Fund303,832$7.86M
Hussman Strategic Advisors, Inc.126,000$3.26M
Two Sigma Advisers, LP94,800$2.45M
Campbell & CO Investment Adviser LLC78,345$2.03M
Global Alpha Capital Management Ltd.68,360$1.77M
Quantbot Technologies LP67,242$1.74M
Integrated Quantitative Investments LLC64,826$1.68M
Engineers Gate Manager LP56,498$1.46M
Diadema Partners LP48,025$1.24M
Radcliffe Capital Management, L.P.39,831$1.03M
Lighthouse Investment Partners, LLC28,415$735.4K
Guggenheim Capital LLC25,224$652.8K
Schonfeld Strategic Advisors LLC23,304$603.1K
OP Asset Management Ltd22,827$590.8K
Skopos Labs, Inc.20,064$522.9K
Bokf, NA19,844$513.6K
Versor Investments LP18,900$489.1K
Brevan Howard Capital Management LP16,662$431.2K
Axq Capital, LP15,316$396.4K
Fox Run Management, L.L.C.14,092$364.7K
Persistent Asset Partners Ltd12,962$335.5K
ProShare Advisors LLC10,568$273.5K
Tudor Investment Corp Et Al9,341$241.7K
Quest Partners LLC9,304$240.8K
Rafferty Asset Management, LLC9,285$240.3K
Abacus Wealth Partners, LLC8,495$219.9K
Toroso Investments, LLC8,411$217.7K
Swiss Life Asset Management Ltd7,968$206.2K
Canada Pension Plan Investment Board7,700$199.3K
Roxbury Financial LLC6,222$161.0K
Estate Planners Group, LLC3,310$85.7K
Wolverine Asset Management LLC3,000$77.6K
Acadian Asset Management LLC2,907$75.0K
Kestra Advisory Services, LLC1,869$48.4K
Torren Management, LLC374$9.68K
SRS Capital Advisors, Inc.178$4.61K
CoreCap Advisors, LLC166$4.30K
Quarry LP150$3.88K
Daiwa Securities Group Inc.128$3.00K
Spire Wealth Management21$543
Flagship Harbor Advisors, LLC7$181
Dunhill Financial, LLC1$24

Not filed for Q1 2026 yet (5)

Institutions that held Pacira BioSciences, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PCRX in Q4 2025 that haven't filed for Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Vanguard Group Inc4,812,955$124.6M
Comerica Bank9,376$242.7K
Global Retirement Partners, LLC2,028$52.5K
Litman Gregory Asset Management LLC750$19.4K
CIBC Private Wealth Group, LLC10$259